Phase I trial of intranasal ALN RSV01 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2008
At a glance
- Drugs Asvasiran sodium (Primary)
- Indications Respiratory syncytial virus infections
- Focus Adverse reactions; Pharmacokinetics
- 08 May 2007 Results have been reported.
- 24 Jan 2006 New trial record.